CHROMOCELL THERAPEUTICS CORP (CHRO)
US1711261057 - Common Stock
CHROMOCELL THERAPEUTICS CORP
NYSEARCA:CHRO (11/15/2024, 8:04:03 PM)
Premarket: 0.739 +0.11 (+17.12%)0.631
-0.01 (-1.7%)
Company Profile
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company is headquartered in North Brunswick, New Jersey and currently employs 4 full-time employees. The company went IPO on 2024-02-16. The firm's clinical focus is to selectively target the sodium ion-channel, NaV1.7, as well as other receptors in the NaV family. Its lead compound, CC8464, is designed to address both the underlying condition and mitigate the burning pain symptoms, which erythromelalgia (EM) patients experience by blocking the NaV1.7 sodium channel. CC8464 has completed Phase I study. A total of approximately 207 healthy subjects have been dosed in four Phase I studies (CC8464-1001, CC8464-1002, CC8464-1003, and 1807-CL-0102) with study treatment.
Company Info
CHROMOCELL THERAPEUTICS CORP
685 US Highway One
North Brunswick NEW JERSEY
P: 19176446313
Employees: 4
Website: https://chromocell.com/
CHRO News
an hour ago - ChartmillWhich stocks are moving before the opening bell on Monday?Top movers in Monday's pre-market session
20 days ago - Chromocell Therapeutics CorporationChromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical PainFREEHOLD, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer...
21 days ago - Chromocell Therapeutics CorporationChromocell to Present at Upcoming Fall Investor ConferencesFREEHOLD, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer...
25 days ago - Chromocell Therapeutics CorporationChromocell Announces Amendment to Stock Repurchase PlanFREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer...
2 months ago - Virtual Investor ConferencesLife Sciences Virtual Investor Forum Agenda Announced for September 19thCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
3 months ago - InvestorPlaceCHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q2 2024Chromocell Therapeutics just reported results for the second quarter of 2024.
CHRO Twits
Here you can normally see the latest stock twits on CHRO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
